AKT1 and McLeod neuroacanthocytosis syndrome: We previously described a related and potentially targetable oncogenic mechanism in MLS that involves activation of the IGF1R‐PI3K‐AKT signaling cascade through FUS‐DDIT3‐dependent induction of IGF2 transcription (Trautmann et al, 2017).